Clinical Trial Update: Study on Impact of Edoxaban Treatment in Cancer Patients With Venous Thromboembolism During Antineoplastic Therapy [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the impact of edoxaban for cancer-associated venous thromboembolism during antineoplastic therapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Venous Thromboembolism

Drugs mentioned

• Edoxaban (edoxaban)

Snippet

Sponsor: Gruppo Oncologico Italiano di Ricerca Clinica | Conditions: Thromboembolism, Cancer | Phase 4 | Status: COMPLETED